enEvolv: George Church startup EnEvolv harnesses the power of evolution

A small company co-founded less than a year ago by Harvard genetics professor George Church is looking far beyond drug development for its method of genetic engineering microorganisms. EnEvolv, based at the Venture Development Center on the campus of the University of Massachusetts Boston, uses the power of evolution to create microoganisms that can efficiently and sustainably produce chemicals or enzymes. Those materials can be used not only in pharmaceuticals, but in products ranging from personal…